Articles by Pamela Moore :
Resin is more potent than ever, but CBD levels hold steady
Consumer demand has been pushing the THC potency of herbal cannabis upward for decades, but does that increased potency extend to cannabis resin, and to CBD levels, as well? A new report has answers.
Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD
A study out of St. Michael’s Hospital in Toronto has found prescription synthetic cannabinoids are linked to a 64% increase in death in older patients with chronic obstructive pulmonary disease (COPD). These oral drugs—nabilone and dronabinol—have a chemical structure similar to THC and are often prescribed to treat symptoms associated with COPD, including pain, sleep difficulties and breathlessness.
Children with prenatal cannabis exposure could face mental health risks
Recent recommendations by the Surgeon General of the United States that clinicians and dispensaries discourage pregnant women from using cannabis received support from a new report published in JAMA Psychiatry.
Sanobiotec produces pure, stable synthetic THCV
Contributing to a growing list of synthetically produced cannabis compounds, Sanobiotec announced the synthesis of pure and stable Tetrahydrocannabivarin (THCV).
MJBizCon 2020 rebooting as entirely digital experience; in-person canceled
Marijuana Business Daily announced it is canceling its in-person flagship conference, MJBizCon, for 2020 because of the coronavirus pandemic and will instead offer a five-week digital conference and trade show starting Nov. 2 and culminating with the main event Dec. 2-4.
